Brian Austad

Brian Austad, Ph.D., is a senior scientific leader in chemical and pharmaceutical development with 14+ years of pharmaceutical experience, specializing in process chemistry with a focus on developing novel medicines for unmet needs.

He has extensive experience in natural product synthesis and natural product derivatives; complex chemistry; and optimizing API synthetic routes and manufacturing.

Brian has been a Sr. Advisor in Chemical Development with Rondaxe Pharma and was director of Process Chemistry at Infinity Pharmaceuticals where he established and built a highly effective process chemistry group responsible for the API development and manufacture of all Infinity clinical programs.

He has previously worked at Eisai Research Institute as a scientist and project leader in process chemistry where he was a core contributor the development and manufacture of Halavan®, a fully synthetic derivative of the highly complex marine natural product Halichondrin B, for the treatment of breast cancer.

Brian received his B.S. degree in Chemistry from University of Wisconsin – Eau Claire and his Ph.D. in Synthetic Organic Chemistry from the University of Wisconsin – Madison with Prof. Steven D. Burke.

Brian Austad is the SVP, Pharmaceutical Sciences at Karyopharm Therapeutics, based in United States, North America. With a background in Health Care, Brian Austad has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.